Identification and Evaluation of Coronavirus Replicase Inhibitors Using a Replicon Cell Line
Advances in Experimental Medicine and Biology - United States
doi 10.1007/978-0-387-33012-9_111
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2006
Authors
Publisher
Springer US